Home › Merck to buy Cubist Pharmaceuticals for $9.5 billion
 

Keywords :   


Merck to buy Cubist Pharmaceuticals for $9.5 billion

2014-12-08 14:13:42| Biotech - Topix.net

Drug giant Merck said it will buy Cubist and a slate of medicines administered in the hospital setting, many for bacterial infections, for about $9.5 billion, for $102 a share in cash. The deal represents a 35 percent premium to Cubist's average stock price in the last five trading days, Merck said in a statement on Monday.

Tags: buy billion pharmaceuticals merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »